Status:
COMPLETED
Tailored Mobile Text Messaging to Reduce Problem Drinking
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol-Related Disorders
Alcohol Use Disorders
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This study is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcohol consumption; and...
Detailed Description
The proposed development study entitled, Tailored Mobile Text Messaging to Reduce Problem Drinking is designed to develop and test a tailored adaptive text messaging/short message service (SMS) interv...
Eligibility Criteria
Inclusion
- Participants must:
- be fluent and able to read in English at the eighth grade level
- be between the ages of 21 and 65
- have an estimated average weekly consumption of greater than 15 or 24 standard drinks per week for women and men, respectively
- be willing to reduce their drinking to non-hazardous levels
- be willing to provide informed consent
- own a mobile phone and have an active email address and are willing to receive and respond to up to 115 text messages total per month (average = 50)
Exclusion
- Participants will be excluded from the study if they
- present with significant substance use or a current substance use disorder (for any substance other than alcohol, nicotine, or caffeine), which is defined as greater than once weekly use in the past month
- present with a serious psychiatric illness or suicide risk as measured by previous inpatient treatment, medications for psychosis or recent suicidality; demonstrate clinically severe alcoholism, as evidenced by physical withdrawal symptoms or a history of serious withdrawal symptoms (e.g., hallucinations, seizures, or delirium tremens), and score greater than 12 on the Short Alcohol Withdrawal Scale (SAWS)
- express a desire or intent to obtain additional substance abuse treatment while in the study
- report a medical condition that precludes drinking any alcohol; or
- demonstrate cognitive impairment as evidenced a score of less than 7 out of 10 on the consent form quiz
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT01885312
Start Date
February 1 2014
End Date
August 1 2016
Last Update
October 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Feinstein Institute for Medical Research / North Shore-LIJ Health System
Great Neck, New York, United States, 11021